Navigation Links
Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
Date:10/12/2009

nd is invested in more than 50 private companies. The objective of the Novartis Option Fund is to seed innovative companies through initial and follow on investments. The initial investment is coupled with an option to a specific therapeutic program providing early validation for the company's technology by a larger pharmaceutical partner. The Novartis Venture Funds' team of eight investment professionals located in Basel, Switzerland and Cambridge, Massachusetts, brings together extensive expertise in the biotech and pharmaceutical industry and venture capital.

    For more information: http://www.venturefund.novartis.com

    Contact Information:

    Heptares Therapeutics Ltd
    Dr Malcolm Weir
    Phone:  +44(0)1707-358-629
    Mobile: +44(0)7968-947268
    E-mail: malcolm.weir@heptares.com

    Citigate Dewe Rogerson
    Dr Mark Swallow, Dr Chris Gardner
    Phone: +44(0)20-7282-2948
    E-mail: mark.swallow@citigatedr.co.uk


SOURCE Heptares Therapeutics Ltd


'/>"/>
SOURCE Heptares Therapeutics Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
2. Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
3. Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
4. InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting
5. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
6. Reportlinker Adds Stem Cell Therapeutics Markets Report
7. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
8. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
9. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
10. Nektar Therapeutics to Host Conference Call to Discuss Todays Announcement of a New Partnership for NKTR-118 and NKTR-119
11. Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  Pfenex ... quarter 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host a ... a business update.  A press release outlining the financial ... to the call. Please call 1-866-376-8058 (US) ...
(Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation Impact Index (MI3) ... in particular, drug/device combinations. The current system received a score of 0 (range -10 ... Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... 29, 2015 , ... CSSi LifeSciences™ formalized a ... in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and regulatory ... Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical Payment ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... drive somatic, or fully differentiated, human cells back to ... of the significant scientific and social challenges to the ... promise of regenerative medicine. Recent research with mouse and ... is possible, although the current process is inefficient and, ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... highly specific molecular diagnostic test to detect,high-risk strains of ... HPV Assay has been CE marked and is currently ... CE marking and launch of our APTIMA HPV Assay ...
... that a live audio webcast and accompanying slide,presentation will be provided ... Prenatal Diagnostics." Details of the,event are as follows:, What: ... Diagnostics, When: Tuesday, June 3, 2008 ... http://www.sequenom.com , Agenda: Hosted by: ...
Cached Biology Technology:New insights into cellular reprogramming revealed by genomic analysis 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 3Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 4Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 5Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3 2
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... available in French . , A recent ... Human Stress (CSHS) at the Hpital Louis-H. Lafontaine and professor ... changes the structure surrounding a gene involved in regulating mood, ... age. The study published in the journal Psychological ...
... kinds than had been reported in findings published just four ... planet. Hitching rides in the upper troposphere, they,re making their ... North America.For the first time researchers have been able to ... molecular methods to samples from two large dust plumes originating ...
... travel and climate warming could be creating the right conditions ... to a new Cornell University computer model., The model predicts ... and spread by the invasive Asian tiger mosquito, could occur ... in Atlanta from June through September, and year-round in Miami. ...
Cached Biology News:Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood 2Plumes across the Pacific deliver thousands of microbial species to West Coast 2Plumes across the Pacific deliver thousands of microbial species to West Coast 3Chances seen rising for chikungunya outbreaks in NYC, Atlanta, Miami 2
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
...
... suitable for use with a wide range ... to water and some of the higher ... of removing water and organic solvents from ... microplates, vials and round bottom flasks; making ...
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
Biology Products: